School of Medicine
Showing 4,851-4,900 of 5,171 Results
-
Victoria Ward
Clinical Professor, Pediatrics
Current Research and Scholarly InterestsGlobal child health, Health AI in LMICs, preterm birth, human trafficking
https://digitalmedic.stanford.edu/
https://htdatalab.stanford.edu/ -
Roger Warnke
Ronald F. Dorfman, M.B.B.ch., FRCPath, Professor in Hematopathology, Emeritus
Current Research and Scholarly InterestsAs an Emeritus Professor, I no longer have a research laboratory and am now fully retired.
-
Jenli Dawn Waters, MD
Clinical Assistant Professor, Neurosurgery
BioDr. Waters is a board-certified, fellowship-trained neurosurgeon with the Neurosurgery Program at Stanford Health Care. She is also a clinical assistant professor of neurosurgery in the Department of Neurosurgery at Stanford University School of Medicine.
Dr. Waters specializes in treating a wide range of spinal conditions. These treatments include surgery to relieve numbness or pain related to pressure on the spinal cord and procedures to repair or stabilize the spinal column (spine fusion). Her areas of expertise also include diagnosis and treatment of traumatic brain injury and brain and spinal cancers.
Dr. Waters’ research experience includes helping to develop effective strategies for diagnosing
and treating patients with different neurological cancers, including glioblastomas. As a subspecialty medical expert for spine and neurosurgery, she successfully advocated for insurance coverage of state-of-the-art, minimally invasive approaches to treating epilepsy and brain tumors.
Dr. Waters has published her work in peer-reviewed journals, including the Journal of Neurosurgery and the Journal of Neuro-Oncology. She has also authored and co-authored chapters in numerous books describing neurosurgical techniques and the diagnosis and treatment of various neurological conditions, including brain and spinal cord tumors.
Dr. Waters is a member of the Congress of Neurological Surgeons. -
Erin Watson, PsyD, ABPP
Clinical Associate Professor, Medicine - Gastroenterology & Hepatology
BioErin Watson, PsyD, ABPP, is a board-certified clinical health psychologist and Clinical Associate Professor in the Division of Gastroenterology & Hepatology at Stanford University School of Medicine. She specializes in helping people understand and manage the psychological, behavioral, and lifestyle factors that can affect their physical health. Her clinical interests include coping with chronic illness, managing stress and health-related anxiety, making sustainable health behavior changes, and using evidence-based mind-body and behavioral approaches to improve symptoms, functioning, and quality of life.
Dr. Watson has specialized in health psychology and behavioral medicine throughout her education, training, and career. She completed her doctoral training with an emphasis in Primary Care Psychology and Behavioral Medicine, followed by advanced training in health psychology and integrated medical care and a postdoctoral fellowship focused on infectious and liver diseases. Before joining Stanford, she spent more than a decade at the San Francisco VA and UCSF providing behavioral health care within medical settings, including primary care, chronic pain, liver and infectious disease, bariatric medicine, and outpatient health psychology.
At Stanford, Dr. Watson is part of GI & Liver Behavioral Medicine, where she works with adults living with digestive and liver conditions. Her work in psychogastroenterology addresses the important connections between the brain, behavior, and digestive system. She also has a particular interest in advancing psycho-hepatology, which brings health psychology and behavioral medicine into liver care. Her goal is to help patients develop practical skills for coping with illness, managing symptoms and stress, changing health behaviors, and living well alongside chronic medical conditions.
Dr. Watson is a dedicated clinician-educator with more than a decade of experience teaching and supervising psychology trainees and educating healthcare professionals across disciplines. Her current academic work includes research examining behavioral approaches to chronic pain and opioid use through a National Institutes of Health-funded study, as well as a recently funded Patient-Centered Outcomes Research Institute (PCORI) study evaluating behavioral interventions for people living with rare liver diseases. Across her clinical care, research, teaching, and program development, she works to advance the integration of psychological and behavioral science into medical care and improve the health and quality of life of people living with chronic disease. -
Kathleen Watson
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioKathleen Watson, Ph.D., serves as an Assistant Clinical Professor at Stanford University School of Medicine, specializing in Epidemiology and Clinical Research. She co-founded Microclinic International in 2007, where she served as Chief Operating Officer until 2012, focusing on socially-based health interventions for underserved communities.
Dr. Watson's research encompasses various aspects of mental health and metabolism. She investigates the connection between insulin resistance and depression, using computational psychiatry to uncover insights into the interplay of metabolic factors in mental well-being. Additionally, her exploration of cognitive aging examines how metabolic alterations might impact cognitive decline and related disorders. Furthermore, her research in proteomics aims to identify potential biomarkers for severe major depressive disorder. Dr. Watson has recently become a part of the Stanford Autism Center for Excellence Data Core, where she works under the guidance of Dr. Booil Jo. -
Robert Waymouth
Robert Eckles Swain Professor of Chemistry and Professor, by courtesy, of Chemical Engineering
BioRobert Eckles Swain Professor in Chemistry Robert Waymouth investigates new catalytic strategies to create useful new molecules, including bioactive polymers, synthetic fuels, and sustainable plastics. In one such breakthrough, Professor Waymouth and Professor Wender developed a new class of gene delivery agents.
Born in 1960 in Warner Robins, Georgia, Robert Waymouth studied chemistry and mathematics at Washington and Lee University in Lexington, Virginia (B.S. and B.A., respectively, both summa cum laude, 1982). He developed an interest in synthetic and mechanistic organometallic chemistry during his doctoral studies in chemistry at the California Institute of Technology under Professor R.H. Grubbs (Ph.D., 1987). His postdoctoral research with Professor Piero Pino at the Institut fur Polymere, ETH Zurich, Switzerland, focused on catalytic hydrogenation with chiral metallocene catalysts. He joined the Stanford University faculty as assistant professor in 1988, becoming full professor in 1997 and in 2000 the Robert Eckles Swain Professor of Chemistry.
Today, the Waymouth Group applies mechanistic principles to develop new concepts in catalysis, with particular focus on the development of organometallic and organic catalysts for the synthesis of complex macromolecular architectures. In organometallic catalysis, the group devised a highly selective alcohol oxidation catalyst that selectively oxidizes unprotected polyols and carbohydrates to alpha-hyroxyketones. In collaboration with Dr. James Hedrick of IBM, we have developed a platform of highly active organic catalysts and continuous flow reactors that provide access to polymer architectures that are difficult to access by conventional approaches.
The Waymouth group has devised selective organocatalytic strategies for the synthesis of functional degradable polymers and oligomers that function as "molecular transporters" to deliver genes, drugs and probes into cells and live animals. These advances led to the joint discovery with the Wender group of a general, safe, and remarkably effective concept for RNA delivery based on a new class of synthetic cationic materials, Charge-Altering Releasable Transporters (CARTs). This technology has been shown to be effective for mRNA based cancer vaccines. -
Kenneth Weber, DC, PhD
Assistant Professor (Research) of Anesthesiology, Perioperative and Pain Medicine (Adult Pain) and, by courtesy, of Neurosurgery (Adult Neurosurgery) and of Radiology (Neuroimaging and Neurointervention)
BioDr. Weber directs the Neuromuscular Insight Lab. Dr. Weber's research seeks to develop quantitative markers of sensory and motor function, including pain, using machine-learning and advanced brain, spinal cord, and musculoskeletal magnetic resonance imaging. Dr. Weber aims to use these techniques to better understand the neuropathology of neurological and musculoskeletal conditions and discover more effective treatments and preventative strategies.
-
Leila Wehbe
Associate Professor of Biomedical Data Science and of Neurology and Neurological Sciences (Adult Neurology)
BioLeila Wehbe is an Associate Professor of Biomedical Data Science and of Neurology and Neurological Sciences at Stanford University. Her research focuses on understanding how the human brain represents and processes information during naturalistic cognition. She brings together neuroscience and machine learning, using tools like fMRI and MEG to build computational models of brain activity during complex cognitive processes such as language comprehension and high-level visual processing. Her work examines what brains and artificial systems can reveal about one another.
-
Mike Tzuhen Wei
Clinical Assistant Professor, Medicine - Gastroenterology & Hepatology
BioDr. Wei was born and raised in Taipei, Taiwan. He went to Stanford for his undergraduate studies in Biology and earned his medical degree at Weill Cornell Medical College. Unable to stay far from the Bay Area, he returned to Stanford where he completed his residency in internal medicine and subsequently his fellowship in gastroenterology. Dr. Wei has specific interests in colorectal cancer and Barrett’s esophagus surveillance as well as reflux diagnosis and management. He has an interest in endoscopic resection of large polyps and had received training under Dr. Shai Friedland, a world expert in this field. Dr. Wei work focuses on evaluating new tools, technologies and techniques in gastrointestinal cancer surveillance and management. He has been involved in running several trials in endoscopic management of polyps and evaluating artificial intelligence applications in gastroenterology. His work has been published in American Journal of Gastroenterology, Gastrointestinal Endoscopy, Clinical Endoscopy, VideoGIE, and Digestive Diseases and Sciences. He was formerly an Associate Editor for the ACG Case Report Journal (2020-2022) and was on the Board of the Northern California Society of Clinical Gastroenterology. When not in clinic or in endoscopy, Dr. Wei enjoys spending time with his family. He and his family enjoy traveling and exploring new restaurants.
-
Katja Gabriele Weinacht, MD, PhD
Assistant Professor of Pediatrics (Stem Cell Transplantation and Regenerative Medicine)
Current Research and Scholarly InterestsPediatric Hematopoietic Stem Cell Transplantation
DiGeorge Syndrome
Genetic Immune Diseases
Immune Dysregulation -
Ann Weinacker
Professor of Medicine (Pulmonary and Critical Care)
On Leave from 2026-09-08 To 2027-09-07Current Research and Scholarly InterestsDr. Weinacker's research interests center around ICU outcomes. Her specific interests include primary graft dysfunction in lung transplant recipients.
-
Eva Weinlander
Clinical Professor, Medicine - Primary Care and Population Health
Current Research and Scholarly InterestsWomen's Health
Mind Body Medicine
Chronic Disease Management -
Dana Weintraub
Member, Maternal & Child Health Research Institute (MCHRI)
Current Research and Scholarly InterestsResearch interests include: 1) Childhood obesity, community-based interventions to increase physical activity 2) Impact of medical-legal collaboration on child and family health.
-
Thomas G Weiser, MD, MPH
BioDr. Thomas Weiser is a general, emergency, and trauma surgeon, and surgical intensivist. He treats and cares for injured patients and those with acute surgical emergencies as well as manages critically ill surgical patients in the Intensive Care Unit.
His research has focused on evaluating the role surgical care plays in the delivery of health services in resource poor settings, in particular low and middle income countries. He is interested in barriers to access and provision of surgical care, the quality of surgical services, and outcomes research as well as the science of implementation, how improvements can be made, and how to strengthen compliance with best practices and change behaviors for the better. He also has an interest in domestic policy as it relates to trauma outcomes, trauma systems, insurance coverage and costs of care, and firearm violence.
Dr. Weiser's efforts have led to improvements in the safety and reliability of surgical service, the quality of surgical care delivered globally, and improvements team dynamics, function, and communication. He works closely with Lifebox, a nonprofit focused on improving surgical and anesthetic safety worldwide, where he was previously the Consulting Medical Officer. Lifebox delivers programs throughout the world in combination with local partners and includes the procurement and distribution of low cost devices to improve the safety of care (including pulse oximeters for the routine monitoring of patients undergoing anesthesia and surgical headlights to safeguard care during power outage) and Clean Cut, a surgical infection prevention and control program that has reduced complications by up to 50%. This work safeguards millions of surgical patients every year.
From 2006-2009, he was part of the World Health Organization’s Safe Surgery Saves Lives program where he quantified the global volume of surgery and created, implemented, evaluated, and promoted the WHO Surgical Safety Checklist. He was part of the Lancet Commission on Global Surgery, the World Bank Disease Control Priorities Program, and a Gates Grand Challenge awardee.
From 2022-2026 he was the Program Director of Surgery: Assess/Validate/Expand (SAVE) at Wellcome Leap. His current research efforts aim to accelerate computer vision models for quantifying surgical performance and identifying mechanisms to predict patient recovery trajectories following surgery. -
Eric A Weiss, MD, FACEP
Professor of Emergency Medicine at the Stanford University Medical Center, Emeritus
Current Research and Scholarly InterestsMy focus of research is wilderness medicine, including hypothermia, heat illness, altitude illness, improvised medical care in austere environments and wound care. I also have a strong interest in Disaster Medicine, Travel Medicine and International Health, and Pandemics.
-
Eric L. Weiss, MD, DTM&H
Current Research and Scholarly InterestsIgnorance of Hepatitis A Among Travelers (writing up data).Travelers Neglecting to Seek Pre Travel Medicine Advice (writing up data).Fluoroquinolones in the Treatment of Complicated Urinary Tract Infections (new ED study)
-
Irving Weissman
Virginia & D.K. Ludwig Professor of Clinical Investigation in Cancer Research, Professor of Pathology, and of Developmental Biology
Current Research and Scholarly InterestsStem cell and cancer stem cell biology; development of T and B lymphocytes; cell-surface receptors for oncornaviruses in leukemia. Hematopoietic stem cells; Lymphocyte homing, lymphoma invasiveness and metastasis; order of events from hematopoietic stem cells [HSC] to AML leukemia stem cells and blood diseases, and parallels in other tissues; discovery of tumor and pathogenic cell 'don't eat me' and 'eat me' signals, and translation into therapeutics.
-
Chad S. Weldy, M.D., Ph.D.
Assistant Professor of Medicine (Cardiovascular Medicine)
Current Research and Scholarly InterestsThe Weldy Lab studies how human genetic variation drives vascular dysfunction, inflammation, and cardiovascular disease. We integrate human genetics, epigenetics, single-cell genomics, RNA biology, and experimental models to define causal mechanisms and identify new therapeutic opportunities.
Led by Chad S. Weldy, MD, PhD, the lab focuses on questions at the intersection of cardiovascular genetics, vascular biology, and RNA-mediated regulation, with particular interest in smooth muscle cell phenotypic modulation, innate immune signaling, and mechanisms of disease susceptibility governed by epigenetic memory.
Our work is grounded in the idea that genetic discovery can do more than identify risk. It can reveal the biology that matters most and point toward more precise strategies for prevention and treatment.
https://weldylab.org/ -
Andy Wen
Clinical Professor, Pediatrics - Critical Care
BioDr. Andy Y. Wen joined the Division of Pediatric Critical Care Medicine at Stanford University School of Medicine in 2019. He received his B.A. degree in Molecular Biology & Biochemistry at Rutgers University, and his medical degree from Rutgers Robert Wood Johnson Medical School. He completed a Pediatrics Residency Training Program at the State University of New York Downstate Medical Center and a Pediatric Critical Care Medicine Fellowship Training Program at the University of California Los Angeles.
After briefly working for Kaiser Permanente Southern California Permanente Medical Group, Dr. Wen joined the Division of Pediatric Critical Care at NYU School of Medicine. He assumed the role of Bellevue Hospital PICU medical director and helped to expand Bellevue's Pediatric Trauma Program and Pediatric Critical Care Transport Services for the New York City (NYC) public hospital system, NYC Health & Hospitals. During the 2014 to 2016 Ebola outbreak in West Africa, Dr. Wen was a member of the Special Pathogens Program at Bellevue Hospital, which was one of only four institutions in the US to treat a patient with Ebola and helped established the National Ebola Training and Education Center (NETEC).
While at UCLA, Dr. Wen received a T32 Training Grant to perform research investigating the role of transcription factor CREB in innate immune function using a murine model for AML. At NYU, his research projects included analyzing transfusion practices in the PICU, quality improvement projects targeting patients at high risk for unplanned extubation, and exploring the utility of NIRS as an early predictor of seizure activity. Dr. Wen is a member of Pediatric Acute Lung Injury & Sepsis Investigators (PALISI) and has been involved in multi-center studies looking at critical care patients with Bronchiolitis and COVID-19. Dr. Wen is the USA Editor for Journal of Pediatric Intensive Care and has reviewed abstracts for PAS, SCCM, and AMIA. His educational efforts have included teaching Pediatric Fundamental Critical Care Support (PFCCS) courses, helping develop a Pediatric Residency Simulation course curriculum, and helping develop a Point-of-Care Ultrasound course for critical care advanced practice providers.
At Stanford University School of Medicine, Dr. Wen is in charge of Regional Pediatric Critical Care Outreach with a goal to promote medical education and expand the Stanford Children’s Health network to improve access for sick children in need of high quality care. Dr. Wen provides clinical services at both John Muir Medical Center and Lucile Packard Children’s Hospital. -
Paul Wender
Francis W. Bergstrom Professor and Professor, by courtesy, of Chemical and Systems Biology
Current Research and Scholarly InterestsMolecular imaging, therapeutics, drug delivery, drug mode of action, synthesis
-
Kirsti Weng Elder MD/MPH
Clinical Associate Professor, Medicine - Primary Care and Population Health
BioDr. Weng was the Section Chief of General Primary Care from 2020-2023. Dr..Weng has served in roles as Medical Director, and leader of care programs as well as improvement projects. She enjoys leading doctors and strives to inspire those around her to practice patient-centered care as well as physician self-care. She is a leader in organizational change and physician management. As a leader in primary care re-design, she is passionate about balancing the needs of the patient, provider and health care institution. She is an advocate of Mindfulness Self-compassion. Dr Weng is currently semi-retired. She works in the Express Care Clinic as a provider and does individual life and executive coaching.
Kirsti Weng Elder has over 35 years of experience caring for patients in primary care, urgent care and in the hospital. She is a teacher of students and residents. She practices with an emphasis on musculoskeletal care as she feels fitness is a foundation for wellness.
Kirsti supports community health and care for the underserved. Outside of work she enjoys biking, reading and spending time with her 8 children. She is on the board of the Valley Health Foundation. -
Wen-Kai Weng, MD, PhD
Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy) and, by courtesy, of Dermatology
Current Research and Scholarly InterestsMy research interest is on immunotherapy (including allogeneic transplant) of cancer. I have studies the mechanism of monoclonal antibody therapy in lymphoma patients and am currently working on designing new strategy to enhance the clinical efficacy of antibody therapy by infusing expanded NK cells. I am also interested in using tumor vaccine along with hematopoietic cell transplant.
-
Gerlinde Wernig
Associate Professor of Pathology
Current Research and Scholarly InterestsFibrotic diseases kill more people than cancer in this country and worldwide. We believe that scar-forming cells called fibroblasts are at the core of the fibrotic response in parenchymal organ fibrosis in the lung, liver, skin, bone marrow and tumor stroma. At the cellular level we think of fibrosis as a step wise process which implicates inflammation and fibrosis. We seek to identify new effective immune therapy targets to treat fibrotic diseases.
-
Marius Wernig
Professor of Pathology and, by courtesy, of Chemical and Systems Biology
Current Research and Scholarly InterestsEpigenetic Reprogramming, Direct conversion of fibroblasts into neurons, Pluripotent Stem Cells, Neural Differentiation: implications in development and regenerative medicine
-
Dee W. West
Professor of Health Research and Policy, Emeritus
Current Research and Scholarly Interests- Cancer etiology (diet, familial, genetic), especially breast, prostate and colon cancer
- Cancer surveillance (Cancer registration, cancer patterns)
- Cancer outcomes (Survival, quality of life, quality of care) -
Robert West
Sabine Kohler, MD, Professor of Pathology
On Partial Leave from 2026-09-01 To 2026-10-31Current Research and Scholarly InterestsRob West, MD, PhD, is a Professor of Pathology at Stanford University Medical Center. He is a clinician scientist with experience in translational genomics research to identify new prognostic and therapeutic markers in cancer. His research focus is on the progression of neoplasia to carcinoma. His lab has developed spatially oriented in situ methods to study archival specimens. He also serves as a surgical pathologist specializing in breast pathology.
-
M. Brandon Westover, MD, PhD
Professor of Neurology and Neurological Sciences (Adulty Neurology) and, by courtesy, of Biomedical Data Science and of Psychiatry and Behavioral Sciences
BioDr. M. Brandon Westover is a board-certified, fellowship-trained epilepsy specialist, clinical neurophysiologist, and neurologist with Stanford Health Care. He is also a professor in the Department of Neurology and Neurological Sciences at Stanford University School of Medicine and director of the Stanford Epilepsy Center.
Dr. Westover specializes in caring for adults with epilepsy and other neurological conditions. He focuses on developing automated tools that improve the quality and reach of his patients' care. He also treats patients with life-threatening unrelenting seizures (status epilepticus), reduced blood flow to the brain (cerebral ischemia), and reduced oxygen to the brain (anoxic brain injury). In addition, he helps patients experiencing delirium, seizures, and sleep disorders.
Dr. Westover's research develops artificial intelligence technology to protect and improve brain health. His interests include predicting seizures and detecting and forecasting disorders of memory, cognition, and consciousness—such as delirium and coma—in older adults. His work has also used deep learning to estimate the risk of developing epilepsy after a brain injury from brain-wave recordings (electroencephalograms, or EEGs).
Dr. Westover has published his research in leading peer-reviewed journals, including Neurology, JAMA Neurology, Annals of Neurology, Epilepsia, the Journal of the American Medical Informatics Association, and Lancet Digital Health. He has presented his work at international, national, and regional meetings, including the annual meetings of the American Epilepsy Society, the American Clinical Neurophysiology Society, the American Academy of Neurology, and SLEEP.
